-
Announcement on Progress in Repurchasing Company Shares
-
2019 Semi-Annual Report Reveals Informative Announcement
-
Pre-Disclosure Reminder Announcement on Shareholders Holding More Than 5％ of Shares
-
Announcement on Progress in Repurchasing Company Shares1
-
Announcement on the progress of investment in Liaoning Boao Biopharmaceutical Co., Ltd.
-
Legal Opinion Of Lepu Medical's First Extraordinary Shareholder Meeting In 2019
-
Announcement of Resolutions of the First Extraordinary Shareholders' General Meeting in 2019
-
Announcement on Receiving the Notice of Resumption Review of the Administrative License Application of the China Securities Regulatory Commission
-
Lepu Medical: Announcement on Participating in a Group Reception Day for Investors in Listed Companies in Shenzhen and Beijing
-
Lepu Medical: Announcement on Receiving Notification of Administrative Licensing Resumption Review of China Securities Regulatory Commission
-
Lepu Medical: 2019 Semiannual Results Preview
-
Lepu Medical: Announcement of Resolutions of the 23rd Meeting of the Fourth Board of Directors
-
Lepu Medical: Announcement of Resolutions of the 22nd Meeting of the 4th Supervisory Board
-
Lepu Medical: Announcement on Partial Equity Pledge of Controlling Shareholders and Release of Pledge
-
Lepu Medical: Announcement on Providing Guarantee for the Holding Subsidiary Zhejiang Lepu Pharmaceutical Co., Ltd.
-
Lepu Medical: Notice on Holding the First Extraordinary Shareholders' Meeting in 2019
-
Lepu Medical: Announcement on the progress of repurchasing company shares
-
Lepu Medical: Announcement of Resolutions of the 22nd Meeting of the 4th Board of Directors
-
Lepu Medical: Announcement of Resolutions of the 21st Meeting of the Fourth Supervisory Board
-
Lepu Medical: Independent Director's Independent Opinion on the Appointment of the Deputy General Manager
-
Lepu Medical: Announcement on the Company's Application for a Comprehensive Credit Line from a Bank
-
Lepu Medical: Announcement on Appointing Deputy General Manager of the Company
-
Lepu Medical: Announcement on Applying for M
-
Lepu Medical: Prompt Announcement on the Application of Insulin Glargine and Insulin Glargine Injection for Pharmaceutical Production Application
-
Lepu Medical: Announcement on the Acceptance of NMPA Registration Application for Artificial Intelligence ECG Machine
-
Lepu Medical: Announcement on the Acceptance of CFDA Registration Application for Endovascular Drug (Paclitaxel) Eluted Balloon Catheter (Coronary Artery)
-
Lepu Medical: Announcement on Senior Deputy General Manager and Secretary of the Board Increasing Shares in the Company
-
Lepu Medical: Informative Announcement for the First Quarter Report of 2019
-
Lepu Medical: Announcement of Resolutions of the 21st Meeting of the Fourth Board of Directors
-
Lepu Medical: Announcement of Resolutions of the 20th Meeting of the Fourth Supervisory Board
-
Lepu Medical: Independent Director's Independent Opinion on Changes in Accounting Policies
-
Lepu Medical: Announcement on Changes in Accounting Policies
-
Lepu Medical: Announcement on Providing Guarantee for Whollyowned Subsidiary Lepu Pharmaceutical Co., Ltd.
-
Lepu Medical: Legal Opinions of the 2018 Annual Shareholders' Meeting
-
Lepu Medical: Announcement of Resolutions of the 2018 Annual General Meeting of Shareholders
-
Lepu Medical: Announcement of the Issuance of the First Phase of Ultra-short-term Financing Bonds in 2019
-
Lepu Medical: 2018 Work Report of the Supervisory Board
-
Lepu Medical: 2018 Internal Control Self-evaluation Report
-
Lepu Medical: 2018 Social Responsibility Report
-
Lepu Medical: Informative Announcement of 2018 Annual Report Disclosure
-
Lepu Medical: Preview of First Quarter 2019 Results
-
Lepu Medical: Announcement of Resolutions of the 20th Meeting of the Fourth Board of Directors
-
Lepu Medical: Announcement of Resolutions of the 19th Meeting of the 4th Supervisory Board
-
Haitong Securities Co., Ltd.'s semi-annual tracking report for 2019
-
Lepu Medical: Announcement of Public Road Issuance of Convertible Corporate Bonds Online Roadshow
-
Lepu Medical: Prompt Announcement on Public Offering of Convertible Corporate Bonds Prospectus
-
Lepu Medical: Public Issuance of Convertible Corporate Bond Issuance Announcement
-
Lepu Medical: Announcement of Resolutions of the 29th Meeting of the Fourth Board of Directors
-
Lepu Medical: GEM's Public Offering of Convertible Corporate Bonds Prospectus Summary
-
Lepu Medical: GEM Public Offering of Convertible Corporate Bonds Prospectus
-
Lepu Medical: Beijing Zhonglun Law Firm's Work Report on Lawyers'Public Offering of Convertible Corporate Bonds
-
Lepu Medical: Beijing Zhonglun Law Firm's Legal Opinion on Public Offering of Convertible Corporate Bonds by GEM
-
Lepu Medical Beijing Zhonglun Law Firms Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Companys Growth Enterprise Market (4)
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (3)
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (2)
-
Lepu Medical: Beijing Zhonglun Law Firm' s Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company' s Growth Enterprise Market (5)
-
Lepu Medical: Beijing Zhonglun Law Firm' s Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company' s Growth Enterprise Market 1
-
Lepu Medical: Announcement on the Completion of the First Payment of the Ultra Short-Term Financing Bonds in 2019
-
Lepu Medical: Announcement on the Public Issuance of Convertible Corporate Bonds Approved by the China Securities Regulatory Commission1
-
Lepu Medical: Announcement on Adjustment of Share Repurchase Program
-
Lepu Medical: Announcement on Expiry of Share Repurchase Term and Completion of Repurchase
-
Lepu Medical: Announcement on the Progress of Shareholders Holding More Than 5％ of Their Shares
-
Lepu Medical: Independent Opinions of Independent Directors on Matters Related to the 28th Meeting of the Fourth Board of Directors
-
Lepu Medical: Announcement of Resolutions of the 26th Meeting of the Fourth Supervisory Board
-
Lepu Medical: Announcement of Resolutions of the 28th Meeting of the Fourth Board of Directors
-
Lepu Medical: Announcement of General Election and Solicitation of Candidates for the Supervisory Board
-
Lepu Medical: Announcement of Board Election and Solicitation of Candidates
-
Lepu Medical: Announcement On The Completion Of The Payment Of The First Medium Term Bill In 2016
-
Lepu Medical: Announcement of the Issuance of the Second Phase of Ultra-short-term Financing Bonds in 2019
-
Lepu Medical: Announcement on Valsartan Capsules Passing Drug Consistency Evaluation
-
Lepu Medical: Announcement on the Public Issuance Of Convertible Corporate Bonds Approved by the China Securities Regulatory Commission
-
Lepu Medical: Announcement of Resolutions of the Third Extraordinary Shareholders' Meeting in 2019
-
Lepu Medical: Legal Opinion of the Third Extraordinary Shareholders' Meeting in 2019
-
Lepu Medical: Respond to the Letter of Preparation for the Meeting of the Board for the Issuance of Convertible Bonds Issued by the Company Publicly
-
Announcement on the Conformity Evaluation of Amlodipine Besylate Tablets
-
Foreign Exchange Hedging Business Management System
-
Haitong Securities Co., Ltd.'s Verification Opinion on Lepu (Beijing) Medical Devices Co., Ltd.'s Foreign Exchange Hedging Business
-
Independent Opinions of Independent Directors on Matters Related to the 27th Meeting of the Fourth Board of Directors of the Company
-
2019-095 2019 Third Quarter Report Disclosure Informative Announcement
-
2019-094 Notice Regarding the Convening of the Third Extraordinary General Meeting of 2019
-
2019-093 Announcement on Applying for a Loan from the Beijing Branch of China Development Bank
-
2019-092 Announcement on Changes in Accounting Policies
-
2019-090 Announcement on Providing Guarantee for Whollyowned Subsidiary Lepu Holdings Co., Ltd.
-
2019-089 Announcement On The Application Of A Foreign-owned Syndicated Loan By A Wholly-owned Subsidiary, Lepu Holdings Co., Ltd.
-
2019-087 Announcement of Resolutions of the 25th Meeting of the Fourth Supervisory Board
-
2019-086 Announcement of Resolutions of the 27th Meeting of the Fourth Board of Directors
-
Reply To The Letter Requesting The Preparation Of The Meeting Of The Review Committee Of Lepu (beijing) Medical Devices Co., Ltd.
-
2019 First Three Quarter Results Forecast
-
Announcement on Progress in Repurchasing Company Shares
-
Notice on Convening the Second Extraordinary Shareholders' Meeting in 2019
-
Announcement of Resolutions of the 26th Meeting of the Fourth Board of Directors
-
Announcement on the Centralized Procurement of Clopidogrel Hydrogen Sulfate Tablets and Atorvastatin Calcium Tablets in Selected Regions of the Alliance
-
Announcement on Changes in Accounting Policies
-
Announcement on the Revision of the Public Offering of Convertible Corporate Bonds
-
Announcement on the Risk Prompts for Dilutive Current Returns of Convertible Corporate Bonds and the Filling Measures (Second Revision)
-
Public Issuance of Convertible Corporate Bonds (Second Revision)
-
Demonstration and Analysis Report of Public Issuance of Convertible Corporate Bonds (Second Revision)
-
Independent Opinions of Independent Directors on Issues Related to the 25th Meeting of the Fourth Board of Directors of the Company
-
Announcement of Resolutions of the 24th Meeting of the Fourth Supervisory Board
-
Announcement of Resolutions of the 25th Meeting of the Fourth Board of Directors
-
Feasibility Report on the Use of Raised Funds (Second Revision)
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (2)
-
Lepu Medical: Statement of Independent Director Nominee (2)
-
Lepu Medical: Announcement on the Company's Application for Credit Lines with Banks
-
Lepu Medical: 2019 Annual Results Express
-
Lepu Medical: Announcement on the Implementation of the Shareholding Reduction Plan for Shareholders Holding More Than 5％
-
Lepu Medical: Announcement on the Company's Application for a Credit Line from a Bank.PDF
-
Lepu Medical: Announcement of Resolutions of the Second Meeting of the Fifth Board of Directors
-
Lepu Medical: Announcement on the Approval of NMPA Registration for Artificial Intelligence "ECG Analysis Software" (AI-ECGPlatform)
-
Lepu Medical: Announcement on the Selection of New Coronavirus Nucleic Acid Testing Units in Beijing
-
Lepu Medical: Announcement on the Approval of NMPA Registration for Two Medical Angiography X-Ray Machines
-
Lepu Medical: 2019 Annual Results Preview
-
Lepu Medical: Special Audit Report on Funds Replacement
-
Lepu Medical: Haitong Securities Co., Ltd.'s Verification Opinions on the Company's Use of the Proceeds to Replace the Self-Funding Funds Invested in Projects Raised in Advance
-
Lepu Medical: Announcement on the use of raised funds to replace self-raised funds previously invested in fundraising projects
-
Lepu Medical: Announcement on the Acceptance of NMPA Registration Application for Cutting Balloon System
-
Lepu Medical: Independent Opinions Of Independent Directors On Matters Related To The First Meeting Of The Fifth Board Of Directors
-
Lepu Medical: Announcement of Resolutions of the First Meeting of the Fifth Supervisory Board
-
Lepu Medical: Announcement of Resolutions of the First Meeting of the Fifth Board of Directors
-
Lepu Medical: Haitong Securities Co., Ltd.'s Listing Sponsorship Of The Company's Public Offering Of Convertible Corporate Bonds
-
Lepu Medical: Public Offering of Convertible Corporate Bonds Listing Announcement
-
Lepu Medical: Beijing Zhonglun Law Firm's Legal Opinion on the Public Offering of Convertible Corporate Bonds by the Company's Growth Enterprise Market on the Shenzhen Stock Exchange
-
Lepu Medical: Legal Opinion of the First Extraordinary Shareholders' Meeting in 2020
-
Lepu Medical: Announcement of Resolutions of the First Extraordinary General Meeting of Shareholders in 2020
-
Lepu Medical: Announcement on Signing Tripartite Supervision Agreement on Raised Funds
-
Lepu Medical: Announcement on the Implementation of the First Phase of Employee Stock Ownership Plan
-
Lepu Medical: Announcement of the Results of the Public Issuance of Convertible Corporate Bonds
-
Lepu Medical: Notice on Convening the First Extraordinary Shareholders' Meeting in 2020
-
Lepu Medical: Announcement on Election of Staff Supervisors of the Fifth Supervisory Board
-
Lepu Medical: Announcement of the Results of Online Issuance of Convertible Corporate Bonds
-
Lepu Medical: Statement of Nominee of Independent Director (3)
-
Lepu Medical: Statement of Independent Director Nominee (1)
-
Lepu Medical: Statement of Independent Director Candidate (Gan Liang)
-
Lepu Medical: Statement of Independent Director Candidate (Zhi Yi)
-
Lepu Medical: Statement of Independent Director Candidate (Cao Lu)
-
Lepu Medical: Independent Opinions of Independent Directors on the Reelection of the Company's Board of Directors and the Selection of Candidates for the Fifth Board of Directors
-
Lepu Medical: Announcement of Resolutions of the 27th Meeting of the Fourth Supervisory Board
-
Lepu Medical: Announcement of Resolutions of the 30th Meeting of the Fourth Board of Directors
-
Lepu Medical: Announcement of Online Success Rate and Priority Placement of Convertible Corporate Bonds
-
Lepu Medical: Announcement of Public Issuance of Convertible Corporate Bonds
-
Lepu Medical: Haitong Securities Co., Ltd.'s Issuance Letter Of Sponsorship For The Public Issuance Of Convertible Corporate Bonds By The Gem
-
Lepu Medical: Public Issuance of Convertible Corporate Bond Credit Rating Report
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (5)
-
2019-091 Announcement on the Company's Development of Foreign Exchange Hedging Business
-
Lepu Medical: 2018 Annual Audit Report
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (5)
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (4)
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (3)
-
Lepu Medical: Beijing Zhonglun Law Firm's Supplementary Legal Opinion on the Public Issuance of Convertible Corporate Bonds by the Company's Growth Enterprise Market (1)
en 
Email Us: